Evidence map›Paper›PMID 41473889›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2025

Building a transdisciplinary network to improve survival in children with cancer in Colombia: seeds to forests.

Andres Portilla, Eliana Lopez-Baron, Oscar Ramirez, Eileen Fonseca, Santiago Bolivar, Vivian Piedrahita, Monica L Quijano-Lievano, Karen González, Jesús Ardila, Patricia Montenegro and 12 more

Abstract readCase Reports
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Development of S-IMCICA_V.2: A User-Centered Educational and Decision-Support mHealth App for Early Detection of Childhood Cancer.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Andres PortillaDepartment of Pediatrics Universidad del Valle Cali Colombia Department of Pediatrics, Universidad del Valle, Cali, Colombia.
Eliana Lopez-BaronSchool of Public Health and Information Sciences University of Louisville Louisville, Kentucky United States of America School of Public Health and Information Sciences, University of Louisville, Louisville, Kentucky, United States of America.
Oscar RamirezResearch Unit Fundación POHEMA Cali Colombia Research Unit, Fundación POHEMA, Cali, Colombia.
Eileen FonsecaPediatric Hematology/Oncology Unit HOMI-Fundación Hospital Pediátrico la Misericordia Bogotá Colombia Pediatric Hematology/Oncology Unit, HOMI-Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.
Santiago BolivarSchool of Medicine Pontificia Universidad Javeriana Bogotá Colombia School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Vivian PiedrahitaSchool of Nursing Universidad del Valle Cali Colombia School of Nursing, Universidad del Valle, Cali, Colombia.
Monica L Quijano-LievanoSchool of Health Sciences Universidad del Valle Cali Colombia School of Health Sciences, Universidad del Valle, Cali, Colombia.
Karen GonzálezPediatric Critical Care Unit Hospital Pablo Tobón Uribe Medellín Colombia Pediatric Critical Care Unit, Hospital Pablo Tobón Uribe, Medellín, Colombia.
Jesús ArdilaPediatric Hematology/Oncology Unit Fundación Clínica Infantil Club Noel Cali Colombia Pediatric Hematology/Oncology Unit, Fundación Clínica Infantil Club Noel, Cali, Colombia.
Patricia MontenegroPediatric Hematology/Oncology Unit Clínica Blas de Lezo Cartagena Colombia Pediatric Hematology/Oncology Unit, Clínica Blas de Lezo, Cartagena, Colombia.
German Camacho-MorenoPediatric Infectious Diseases Unit HOMI-Fundación Hospital Pediátrico la Misericordia Bogotá Colombia Pediatric Infectious Diseases Unit, HOMI-Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.
Martha PiñaPediatric Hematology/Oncology Unit Instituto Nacional de Cancerología Bogotá Colombia Pediatric Hematology/Oncology Unit, Instituto Nacional de Cancerología, Bogotá, Colombia.
John LoperaPediatric Hematology/Oncology Unit Instituto Nacional de Cancerología Bogotá Colombia Pediatric Hematology/Oncology Unit, Instituto Nacional de Cancerología, Bogotá, Colombia.
Gloria SuarezPediatric Hematology/Oncology and Bone Marrow Transplant Unit Instituto de Cancerología, Clínica Las Américas Medellín Colombia Pediatric Hematology/Oncology and Bone Marrow Transplant Unit, Instituto de Cancerología, Clínica Las Américas, Medellín, Colombia.
Javier Aguilar-MejiaPediatric Emergency Medicine Unit HOMI-Fundación Hospital Pediátrico la Misericordia Bogotá Colombia Pediatric Emergency Medicine Unit, HOMI-Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.
Wilfrido Coronell-RodriguezDepartment of Pediatrics Universidad de Cartagena Cartagena Colombia Department of Pediatrics, Universidad de Cartagena, Cartagena, Colombia.
Catalina ArangoPediatric Infectious Diseases Unit Hospital San Vicente Fundación Medellín Colombia Pediatric Infectious Diseases Unit, Hospital San Vicente Fundación, Medellín, Colombia.
Eddie PabonPediatric Hematology/Oncology Unit Cancer Institute, Hospital Serena del Mar Cartagena Colombia Pediatric Hematology/Oncology Unit, Cancer Institute, Hospital Serena del Mar, Cartagena, Colombia.
Karina GrilloCali Population-Based Cancer Registry Department of Pathology Universidad del Valle Cali Colombia Cali Population-Based Cancer Registry, Department of Pathology, Universidad del Valle, Cali, Colombia.
Leidy Tovar-PaduaDepartment of Pediatrics University of California San Diego and Rady Children's Health San Diego, California United States of America Department of Pediatrics, University of California San Diego and Rady Children's Health, San Diego, California, United States of America.
Michael LauzardoDepartment of Medicine University of Florida Gainesville, Florida United States of America Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
Paula AristizabalDepartment of Pediatrics University of California San Diego and Rady Children's Health San Diego, California United States of America Department of Pediatrics, University of California San Diego and Rady Children's Health, San Diego, California, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood cancer mortality is disproportionately higher in low- and middle-income countries than high-income countries. The World Health Organization Global Initiative for Childhood Cancer aims for a survival of 60% by 2030. This initiative prioritizes timely diagnosis, access to standardized therapy and supportive care, and prompt management of treatment-related complications. Collaborative work is linked to better performance of health systems and delivery of high-quality care. While collaborative strategies between high- and lower-income countries can advance cancer care in low- and middle-income countries, local and regional initiatives are essential to improve clinical outcomes. The high treatment-related mortality in children with cancer in low- and middle-income countries highlights the critical need to collaborate. To decrease treatment-related mortality in children with cancer in Colombia, a new model of transdisciplinary collaboration was built among Colombian scientific societies (pediatrics, pediatric hematology/oncology, infectious diseases, critical care), academic institutions, grassroots foundations, and the Colombian Childhood Cancer Clinical Outcomes Surveillance System: VIGICANCER. The network supports resource and knowledge exchange to tackle public health challenges related to accessing cancer care for children. It enables the design of targeted and tiered multilevel interventions to enhance quality of care for Colombian children and adolescents with cancer. This transdisciplinary network aims to improve survival in Colombian children with cancer and close the gap with high-income countries by establishing data-informed targets and developing a strategic roadmap to address sepsis, the most actionable cause of treatment-related mortality. Our ultimate goal is to reduce the number of years of life lost, thereby supporting societal progress in Latin America.

Indexed as

Colombiadelivery of health carehealth care disparitiesinterdisciplinary researchNeoplasms

Identifiers

PMID41473889
PMCPMC12746696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.